When it comes to pharmaceutical development, stability is paramount. Many APIs face instability in aqueous phases, necessitating meticulous galenic studies to ensure prolonged stability. At Eurofins CDMO, we recognise the significance of scalability and commercial viability in achieving lasting stability. Our sterile manufacturing service portfolio is designed to elevate your API's stability, driving it to a higher stage of performance. With cutting-edge development laboratories featuring state-of-the-art laboratory scale freeze dryers, we embark on a journey to reshape drug stability.

Eurofins CDMO presents an array of aseptic processing services that cater to diverse drug product configurations. With flexibility to accommodate a wide range of compounds, primary packaging systems, batch sizes, and fill volumes, we are your strategic partner in transforming your Active Pharmaceutical Ingredient or bulk product into Finished Dosage Forms for both clinical trials and commercial use. Our sterile aseptic filling activities adhere to GMP-compliance standards, ensuring your biologics to meet all the requirements.